Results 41 to 50 of about 17,213 (217)

Comparing TAVR and SAVR in the Treatment of Aortic Stenosis

open access: yesThe Heart Surgery Forum
Aortic stenosis (AS) is the most commonly treated valvulopathy worldwide, affecting more than 9.4 million patients. Surgical aortic valve replacement (SAVR) has long been the standard treatment for severe AS.
Ricky Patil   +3 more
doaj   +1 more source

A case of transcatheter prosthetic aortic valve endocarditis

open access: yesJournal of Community Hospital Internal Medicine Perspectives, 2020
Transcatheter aortic valve implantation (TAVR) constitutes an established treatment in inoperable or high perioperative risk patients with severe aortic stenosis.
Muhammad Shabbir Rawala   +3 more
doaj   +1 more source

Speckle tracking strain and ECG heterogeneity correlate in transcatheter aortic valve replacement-induced left bundle branch blocks and right ventricular paced rhythms

open access: yesOpen Heart, 2021
Objective Transcatheter aortic valve replacement (TAVR) complications include left bundle branch block (LBBB) and right ventricular paced rhythm (RVP). We hypothesised that changes in electrocardiographic heterogeneity would correlate better with speckle
Jeffrey J Popma   +9 more
doaj   +1 more source

Endocarditis After Redo TAVR Managed With Medical Treatment and Later TAVR-in-TAVR-in-TAVR

open access: yesJACC: Case Reports
Infective endocarditis after transcatheter aortic valve replacement (TAVR) is a rare but serious condition, with high morbidity and mortality, often requiring surgery.An 89-year-old woman with prior TAVRs (Sapien 3 and Evolut Pro) presented with dyspnea and fever.
Ferro de Brito, Pedro Henrique   +9 more
openaire   +2 more sources

Gutter Rotation Technique for Percutaneous Ipsilateral Retrieval of a Ruptured SAPIEN‐3 Balloon

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Balloon rupture during transcatheter aortic valve replacement (TAVR) with balloon‐expandable valves is a rare but potentially serious complication that may result in incomplete valve expansion, difficult device retrieval, and vascular injury.
Anne Venkata Ganeshkumar   +5 more
wiley   +1 more source

Early Experience With Evoque Transcatheter Tricuspid Valve Replacement in Carcinoid Heart Disease

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Tricuspid regurgitation (TR) is nearly universal in carcinoid heart disease (CHD), but surgical replacement carries significant risk, and CHD was excluded from the landmark TRISCEND II trial. We present seven patients with CHD undergoing Evoque transcatheter tricuspid valve replacement (TTVR) at two tertiary centers.
Jackson S. Burton   +3 more
wiley   +1 more source

Validation of the 2019 Expert Consensus Algorithm for the Management of Conduction Disturbances After TAVR. [PDF]

open access: yes, 2021
OBJECTIVES The aim of this study was to validate the 2019 consensus algorithm in a large cohort of contemporary transcatheter aortic valve replacement (TAVR) patients.
Heg, Dik   +31 more
core   +4 more sources

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya   +9 more
wiley   +1 more source

Predictors of AKR after TAVR.

open access: yes, 2021
Predictors of AKR after TAVR.
Patrick Ohlmann (5746850)   +14 more
core   +1 more source

Dose approach matter? A meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement

open access: yesBMC Cardiovascular Disorders, 2021
Background Transcatheter aortic valve replacement (TAVR) has gained increasing acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical (TA-TAVR) approach were widely adopted while their performances are limited to a few ...
Ruikang Guo   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy